Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China’s National Methadone Maintenance Treatment Program
Fig 2
The geographical distribution of (A) HCV antibody prevalence and (B) proportion of injecting drug use among MMT clients with baseline HCV test results in China.